India · Delayed Price · Currency is INR Brawn Biotech Statistics
Total Valuation
Brawn Biotech has a market cap or net worth of INR 59.86 million. The enterprise value is 57.05 million.
| Market Cap | 59.86M |
| Enterprise Value | 57.05M |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Brawn Biotech has 3.00 million shares outstanding. The number of shares has decreased by -3.83% in one year.
| Current Share Class | 3.00M |
| Shares Outstanding | 3.00M |
| Shares Change (YoY) | -3.83% |
| Shares Change (QoQ) | +2.13% |
| Owned by Insiders (%) | 52.61% |
| Owned by Institutions (%) | n/a |
| Float | 1.02M |
Valuation Ratios
The trailing PE ratio is 6.12.
| PE Ratio | 6.12 |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 69.91 |
| P/OCF Ratio | 53.51 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.07 |
| EV / Sales | 0.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 66.63 |
Financial Position
The company has a current ratio of 1.13
| Current Ratio | 1.13 |
| Quick Ratio | 0.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -99.64 |
Financial Efficiency
Return on equity (ROE) is 24.43% and return on invested capital (ROIC) is -11.84%.
| Return on Equity (ROE) | 24.43% |
| Return on Assets (ROA) | -1.36% |
| Return on Invested Capital (ROIC) | -11.84% |
| Return on Capital Employed (ROCE) | -7.88% |
| Weighted Average Cost of Capital (WACC) | 4.65% |
| Revenue Per Employee | 18.86M |
| Profits Per Employee | 1.05M |
| Employee Count | 9 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | -9.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.09% in the last 52 weeks. The beta is 0.07, so Brawn Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | +12.09% |
| 50-Day Moving Average | 20.51 |
| 200-Day Moving Average | 20.38 |
| Relative Strength Index (RSI) | 48.00 |
| Average Volume (20 Days) | 715 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Brawn Biotech had revenue of INR 169.78 million and earned 9.41 million in profits. Earnings per share was 3.26.
| Revenue | 169.78M |
| Gross Profit | 24.59M |
| Operating Income | -4.48M |
| Pretax Income | 11,000 |
| Net Income | 9.41M |
| EBITDA | -3.26M |
| EBIT | -4.48M |
| Earnings Per Share (EPS) | 3.26 |
Balance Sheet
The company has 2.81 million in cash and n/a in debt, with a net cash position of 2.81 million or 0.94 per share.
| Cash & Cash Equivalents | 2.81M |
| Total Debt | n/a |
| Net Cash | 2.81M |
| Net Cash Per Share | 0.94 |
| Equity (Book Value) | 43.39M |
| Book Value Per Share | 14.50 |
| Working Capital | 19.50M |
Cash Flow
In the last 12 months, operating cash flow was 1.12 million and capital expenditures -262,340, giving a free cash flow of 856,230.
| Operating Cash Flow | 1.12M |
| Capital Expenditures | -262,340 |
| Depreciation & Amortization | 1.22M |
| Net Borrowing | n/a |
| Free Cash Flow | 856,230 |
| FCF Per Share | 0.29 |
Margins
Gross margin is 14.48%, with operating and profit margins of -2.64% and 5.54%.
| Gross Margin | 14.48% |
| Operating Margin | -2.64% |
| Pretax Margin | 0.01% |
| Profit Margin | 5.54% |
| EBITDA Margin | -1.92% |
| EBIT Margin | -2.64% |
| FCF Margin | 0.50% |
Dividends & Yields
Brawn Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.83% |
| Shareholder Yield | 3.83% |
| Earnings Yield | 15.71% |
| FCF Yield | 1.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |